血管扩张剂在急性心力衰竭救治中的应用原则  

Application principles of vasodilators in the treatment of acute heart failure

作　　者：段芳 崔炜[1] Duan Fang;Cui Wei(First Department of Cardiology,the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China)

机构地区：[1]河北医科大学第二医院心内一科,河北石家庄050000

出　　处：《临床荟萃》2023年第9期773-778,共6页Clinical Focus

摘　　要：急性心力衰竭是心血管内科常见疾病之一,其治疗原则包括减轻心脏前后负荷、改善心脏收缩与舒张功能等。目前,血管扩张剂尚无可行性的充分证据可以作为治疗急性心力衰竭的常用药物,故在临床使用中存争议。本文将静脉血管扩张剂应用于急性心力衰竭患者的病理生理学基础、使用人群、血压控制目标等重点介绍,以期为使用血管扩张剂提供参考。Acute heart failure(AHF)is one of the common diseases in cardiovascular medicine.Its treatment principles include reducing cardiac preload and afterload,and improving cardiac systolic and diastolic function.Currently,evidences supporting the feasibility of vasodilators in the treatment of AHF are scant.The clinical application of vasodilators remains controversial.This review thoroughly described the pathophysiological basis,populations,and blood pressure control goals of intravenous vasodilators in the treatment of AHF,thus providing references for the clinical application.

关 键 词：心力衰竭 血管扩张药 输注 静脉内 

分 类 号：R541.62[医药卫生—心血管疾病]